American Bio Medica (ABMC) Stock Price

American Bio Medica Price

OTC·CLOSED
0
​
Market closed

Revenue at American Bio Medica has contracted by 12.9% per year over the past 19 years to 913,000.00 USD. Earnings per share have declined at 42.4% per year over the last 3 years. American Bio Medica's net margin stands at -154.4%, down from -26.5% several years earlier.

American Bio Medica stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

American Bio Medica business model & stock analysis

American Bio Medica Corp is a US-based company specializing in the development and manufacture of drug testing devices and diagnostic products. The company was founded in 1986 and is headquartered in Kinderhook, New York. Its business model involves developing and producing drug testing devices and diagnostic products used by government agencies, companies, and private customers worldwide. The company also operates a laboratory that conducts diagnostic tests for third parties. Its five business areas include drug tests, medication safety, diagnostics, biometrics, and forensics. The company's products include urine, saliva, and sweat drug tests, as well as medical devices to prevent prescription drug abuse and diagnostic products for various diseases. It also offers biometric instruments and systems for person identification and forensic products for crime investigation. American Bio Medica Corp has been publicly traded since 1992 and has received several awards for its products and innovations. The company is committed to research and development, quality assurance, and accuracy in its products. Overall, it is a leading company in the field of drug testing devices and diagnostic products and is expected to continue to evolve in the future.

Frequently asked questions about American Bio Medica

American Bio Medica Corp is a pharmaceutical company that specializes in developing and manufacturing diagnostic tests for drug abuse. Their business model revolves around producing reliable, accurate, and cost-effective test kits that detect drug usage. With a focus on innovation and quality, American Bio Medica Corp aims to provide healthcare professionals and organizations with effective tools to identify and prevent substance abuse. Through their dedication to research and development, they strive to improve public health and safety by offering advanced diagnostic solutions in the field of drug testing.

American Bio Medica Corp is primarily active in the healthcare and diagnostic industries.

The main competitors of American Bio Medica Corp in the market include companies such as Abbott Laboratories, Alere Inc., and Thermo Fisher Scientific.

American Bio Medica Corp is a leading provider of diagnostic testing solutions. Founded in 1984, the company specializes in the development, manufacturing, and marketing of immunoassay tests for drugs of abuse. With a commitment to accuracy and reliability, American Bio Medica Corp has built a strong reputation for its high-quality products and cutting-edge technology. The company's extensive product portfolio includes tests for drugs such as cocaine, marijuana, amphetamines, and opioids. With years of experience in the industry, American Bio Medica Corp continues to innovate and deliver solutions that meet the evolving needs of healthcare professionals and organizations worldwide.

American Bio Medica Corp has achieved several significant milestones throughout its history. Some of these notable accomplishments include the development of innovative drug testing solutions, earning certifications and regulatory approvals for their products, and establishing strategic partnerships with industry leaders. The company has successfully expanded its product portfolio, offering a comprehensive range of rapid drug testing kits and laboratory services. American Bio Medica Corp has also demonstrated its commitment to research and development, continuously improving its technologies to meet evolving market demands. With its dedication to quality and innovation, American Bio Medica Corp maintains its position as a leading provider of drug testing solutions in the industry.

American Bio Medica Corp is primarily present in the United States.

American Bio Medica Corp represents values of innovation, quality, and commitment to public health. The company strives to develop and produce cutting-edge diagnostic products and healthcare solutions that improve patients' lives. American Bio Medica Corp places great emphasis on delivering accurate and reliable testing solutions to various healthcare providers, enabling them to make informed decisions for their patients. The company's corporate philosophy is centered around providing excellent customer service, fostering strong partnerships, and continuously advancing its technologies to meet the evolving needs of the medical industry. American Bio Medica Corp is dedicated to making a positive impact on global healthcare outcomes through its products and services.

American Bio Medica Corporation is a leading global provider of point-of-care drug and alcohol tests, as well as services related to the drug and alcohol screening industry. The company has been in business since 1986 and is headquartered in Kinderhook, New York. One of the company's main areas of focus is the development, manufacturing, and distribution of drug and alcohol tests used in the healthcare industry, criminal justice system, workplace testing, and military population. The company's tests are fast and reliable, delivering results within minutes. They are available in various formats, including urine and saliva tests, and adhere to the highest quality and safety standards. Another key segment of American Bio Medica Corporation is the workplace drug testing market. The company offers a variety of tests and services to help employers implement successful drug screening programs. In addition to providing the necessary tests, the company also offers training, support, and consulting services to help businesses effectively implement their testing programs. In addition to the workplace drug testing market, American Bio Medica Corporation is also involved in the criminal justice sector. The company offers products and services that can be used for drug screening of individuals in the criminal justice system. These tests can help ensure compliance with probation requirements and ensure that individuals struggling with drug problems receive the appropriate help. Another important area for the company is the use of drug tests in healthcare. American Bio Medica Corporation provides a variety of tests that can be used by physicians, clinics, and other medical professionals for quick and reliable diagnosis of certain diseases and conditions. In addition to its core business areas, American Bio Medica Corporation also offers services such as training and consulting. The company has a team of experts who can assist customers in improving and optimizing their drug and alcohol screening programs. In summary, American Bio Medica Corporation specializes in the development, manufacturing, and distribution of drug and alcohol tests, as well as related services. The company serves a variety of industries, including workplace testing, criminal justice, and healthcare, offering a wide range of reliable and fast tests that adhere to the highest quality and safety standards. American Bio Medica Corporation is committed to providing its customers with excellent service and support, as well as innovative solutions to enhance their drug and alcohol screening programs.

The revenue cannot currently be calculated for American Bio Medica.

The profit cannot currently be calculated for American Bio Medica.

The P/E ratio cannot be calculated for American Bio Medica at the moment.

The P/S cannot be calculated for American Bio Medica currently.

The Eulerpool Quality Score for American Bio Medica is 4/10.

The ISIN of American Bio Medica is US0246001087. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of American Bio Medica is 912562. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of American Bio Medica is ABMC. The ticker symbol is used to trade American Bio Medica shares on the stock exchange.

Fair ValueTerminal
148.30 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
11,556.96 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website abmc.com
Currency
USD
Initial public offering
Oct 27, 1993
ISIN
US0246001087
Cusip
024600108
Sedol
2029553
Market capitalization
48.10 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1,293.58 %
Last updated Nov 20, 2026, 5:41 AM

American Bio Medica Ticker

OTC · ABMCOTC · ABMC

American Bio Medica FIGI

ABMC:US · BBG000CK8P25ABMC:PQ · BBG000CK8VS4ABMC:UV · BBG000CK8WJ2

All fundamentals and in-depth analysis of American Bio Medica

Our stock analysis for American Bio Medica stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of American Bio Medica. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.